2024 SCCM Congress - Clinical Evidence for Host-Directed Therapeutics (BARDA)

2024 SCCM Congress - Clinical Evidence for Host-Directed Therapeutics (BARDA)

This session will consist of a discussion of the potential opportunity for host-directed therapeutics (HDTs) for treating infectious diseases and impacting critical care medicine. Opportunities and challenges related to the development and repurposing of HDTs will be explored.

  • Provider:Society of Critical Care Medicine
  • Activity Link: https://congress2024.sccm.org/aaStatic.asp?SFP=VFJVUUtHWFdAMTU3NjlAQ29uZ3Jlc3MgRGlnaXRhbA
  • Start Date: 2024-02-01 06:00:00
  • End Date: 2024-02-01 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
  • MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Variable
  • Measured Outcome: Learner Competence, Learner Knowledge
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Critical Care Medicine
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.